The liver and lovastatin
- 1 June 2002
- journal article
- review article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 89 (12), 1374-1380
- https://doi.org/10.1016/s0002-9149(02)02355-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Descriptive epidemiology of acute liver enzyme abnormalities in the general population of central MassachusettsPharmacoepidemiology and Drug Safety, 1999
- Acute Cholestatic Hepatitis Associated With PravastatinAmerican Journal Of Gastroenterology, 1999
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Multiple organ toxicity from addition of erythromycin to long-term lovastatin therapy.Southern Medical Journal, 1998
- Acute Liver FailureNew England Journal of Medicine, 1993
- Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatinAmerican Journal Of Medicine, 1991
- Biochemical Changes and Morphological Alterations of the Liver in Guinea‐Pigs after Administration of Simvastatin (HMG CoA Reductase‐Inhibitor)Basic & Clinical Pharmacology & Toxicology, 1990
- Preclinical evaluation of lovastatinThe American Journal of Cardiology, 1988
- Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodiesHepatology, 1985
- Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activityFEBS Letters, 1976